Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Unknown 2Recruiting 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Neuroendocrine Tumors 1Hyperinsulinism 1Colorectal Neoplasms 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × amino-acid, glucose, and electrolyte solution × Clear all
NCT05475210 2024-03-13

177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors

Molecular Targeting Technologies, Inc.

Phase 1 Unknown
9 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT02032953 2023-03-17

Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 4 Unknown
24 enrolled
Gastrointestinal

Hyperinsulinism, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡